Recruiting
Lymphangiosarcoma+34
RecruitingStudy of trabectedin alone versus trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment
InvestigationalNo placebo
Study of trabectedin alone versus trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment
InvestigationalNo placebo
- Disease:LymphangiosarcomaLiposarcoma+33
- Substances:Ttf-Ngr
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Ttf-Ngr
